These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2589164)

  • 1. Influence of positive inotropic agents on intracellular calcium transients. Part II. Cardiomyopathic hamster hearts.
    Stefenelli T; Wu ST; Parmley WW; Mason DT; Wikman-Coffelt J
    Am Heart J; 1989 Dec; 118(6):1228-36. PubMed ID: 2589164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
    Buser PT; Wu SY; Parmley WW; Jasmin G; Wikman-Coffelt J
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):151-7. PubMed ID: 7786836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of positive inotropic agents on intracellular calcium transients. Part I. Normal rat heart.
    Auffermann W; Stefenelli T; Wu ST; Parmley WW; Wikman-Coffelt J; Mason DT
    Am Heart J; 1989 Dec; 118(6):1219-27. PubMed ID: 2589163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in myocardial performance without a decrease in high-energy phosphate metabolites after isoproterenol in Syrian cardiomyopathic hamsters.
    Camacho SA; Wikman-Coffelt J; Wu ST; Watters TA; Botvinick EH; Sievers R; James TL; Jasmin G; Parmley WW
    Circulation; 1988 Mar; 77(3):712-9. PubMed ID: 3342496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine potentiates amrinone's beneficial effects in moderate but not in advanced heart failure. 31P-MRS in isolated hamster hearts.
    Buser PT; Auffermann W; Wu ST; Jasmin G; Parmley WW; Wikman-Coffelt J
    Circ Res; 1990 Mar; 66(3):747-53. PubMed ID: 2306805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31P MRS study.
    Buser PT; Camacho SA; Wu ST; Higgins CB; Jasmin G; Parmley WW; Wikman-Coffelt J
    Am Heart J; 1989 Jul; 118(1):86-91. PubMed ID: 2662731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of glycolysis with isoproterenol but not digoxin reverses chronic alcohol depression in hamster hearts.
    Auffermann W; Buser P; Wu S; Parmley WW; Wikman-Coffelt J
    Alcohol Clin Exp Res; 1992 Jun; 16(3):505-10. PubMed ID: 1626650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ca2+]i transients in the cardiomyopathic hamster heart.
    Wikman-Coffelt J; Stefenelli T; Wu ST; Parmley WW; Jasmin G
    Circ Res; 1991 Jan; 68(1):45-51. PubMed ID: 1702036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished tolerance of prehypertrophic, cardiomyopathic Syrian hamster hearts to Ca2+ stresses.
    Hano O; Lakatta EG
    Circ Res; 1991 Jul; 69(1):123-33. PubMed ID: 1711422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of drugs on diseased states of the heart. A 31P NMR and [Ca]i study.
    Wikman-Coffelt J; Auffermann W
    Invest Radiol; 1989 Dec; 24(12):976-9. PubMed ID: 2606635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-dependent fluorescence transients during ventricular fibrillation.
    Stefenelli T; Wikman-Coffelt J; Wu ST; Parmley WW
    Am Heart J; 1990 Sep; 120(3):590-7. PubMed ID: 2389696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocyte structure, function, and calcium kinetics in the cardiomyopathic hamster heart.
    Sen LY; O'Neill M; Marsh JD; Smith TW
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1533-43. PubMed ID: 2240250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033.
    Senzaki H; Isoda T; Paolocci N; Ekelund U; Hare JM; Kass DA
    Circulation; 2000 Mar; 101(9):1040-8. PubMed ID: 10704173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lusitropic effects of a Ca2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts.
    Mori M; Takeuchi M; Takaoka H; Yokoyama M
    Cardiovasc Res; 1995 Dec; 30(6):915-22. PubMed ID: 8746206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibrillar Ca2+ sensitivity of cardiomyopathic hamster hearts.
    Heyder S; Malhotra A; Rüegg JC
    Pflugers Arch; 1995 Feb; 429(4):539-45. PubMed ID: 7617444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolysis in heart failure: a 31P-NMR and surface fluorometry study.
    Auffermann W; Wu ST; Parmley WW; Wikman-Coffelt J
    Basic Res Cardiol; 1990; 85(4):342-57. PubMed ID: 2241766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster.
    Whitmer JT
    Circ Res; 1987 Sep; 61(3):396-408. PubMed ID: 3621499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of dobutamine and isoproterenol in ischemic hearts by phosphorus-31 nuclear magnetic resonance spectroscopy.
    Yanagi S; Takeuchi K; Takeda T; Ishikawa M; Miura I
    Jpn Circ J; 1994 May; 58(5):338-50. PubMed ID: 8022049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
    Cunha-Goncalves D; Perez-de-Sa V; Larsson A; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1576-83. PubMed ID: 19713252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of isoproterenol and taurine on heart calcium in normal and cardiomyopathic hamsters.
    Welty MC; Welty JD; McBroom MJ
    J Mol Cell Cardiol; 1982 Jun; 14(6):353-7. PubMed ID: 7131567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.